XML 38 R28.htm IDEA: XBRL DOCUMENT v3.25.1
Revenue and Contract Acquisition Costs (Tables)
 3 Months Ended
Mar. 31, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table summarizes the Company’s disaggregated revenue:
Three Months Ended March 31,
(in millions)20252024
U.S.
$401.7 $317.7 
International
152.4 115.3 
Total Omnipod products
554.1 433.0 
Drug Delivery14.9 8.7 
Total revenue$569.0 $441.7 
Schedules of Concentration of Risk
The percentages of total revenue for customers that represent 10% or more of total revenue were as follows:
Three Months Ended March 31,

20252024
Distributor A25 %25 %
Distributor B24 %31 %
Distributor C
23 %22 %
The percentages of accounts receivable trade for customers that represent 10% or more of total accounts receivable trade were as follows:

March 31, 2025December 31, 2024
Distributor A30 %35 %
Distributor B24 %27 %
Distributor C
13 %15 %
Schedule of Deferred Revenue
Deferred revenue related to unsatisfied performance obligations was included in the following consolidated balance sheet accounts in the amounts shown:
(in millions)
March 31, 2025December 31, 2024
Accrued expenses and other current liabilities$15.4 $12.0 
Other liabilities0.7 2.0 
Total deferred revenue$16.1 $14.0 
Revenue recognized from amounts included in deferred revenue at the beginning of each respective period was as follows:
Three Months Ended March 31,
(in millions)20252024
Deferred revenue recognized$5.6 $3.1 
Schedule of Contract Acquisition Costs
Contract acquisition costs, representing capitalized commission costs related to new customers, net of amortization, were included in the following consolidated balance sheet captions in the amounts shown:
(in millions)March 31, 2025December 31, 2024
Prepaid expenses and other current assets$21.4 $20.1 
Other assets43.7 40.8 
Total capitalized contract acquisition costs, net$65.1 $60.9